In a report released today, from Leerink Partners reiterated a Buy rating on Zura Bio, with a price target of $11.00. Zura Bio has an analyst consensus of Strong Buy, with a price target consensus of $19.75.
In a report released today, from Leerink Partners reiterated a Buy rating on Zura Bio, with a price target of $11.00.
Zura Bio has an analyst consensus of Strong Buy, with a price target consensus of $19.75.